Literature DB >> 27812761

Let-7f Regulates the Hypoxic Response in Cerebral Ischemia by Targeting NDRG3.

Yaobing Yao1,2, Weiwei Wang3,4, Lijun Jing1, Yiwen Wang1,2, Mingzhe Li1,2, Xiaocan Hou1,2, Jing Wang1,2, Tao Peng1, Junfang Teng1, Yanjie Jia5.   

Abstract

microRNAs are a class of non-coding RNAs including approximately 22 nucleotides in length and play a pivotal role in post-transcriptional gene regulation. Currently, the role of miRNAs in the pathophysiology of ischemic stroke has been the subject of recent investigations. In particular, antagomirs to microRNA (miRNA) let-7f have been found to be neuroprotective in vivo, although the detailed function of let-7f during cerebral ischemia has not been fully illustrated. NDRG3 is an N-myc downstream-regulated gene (NDRG) family member that has been observed in the nuclei in most brain cells. Recently, a NDRG3-mediated lactate signaling, in which stabilized NDRG3 protein can promote angiogenesis and cell growth by activating the Raf-ERK pathway in hypoxia was discovered. In this study, we preliminarily explored the change in the expression of the NDRG3 protein which indicated that NDRG3 protein is an oxygen-regulated protein in neurons in rat cerebral ischemia in vivo and in vitro. We further identified let-7f as an upstream regulator of NDRG3 by the lentiviral transfection of rat cortical neurons and the dual luciferase analysis of human genes. In addition, a dual-color fluorescence in situ hybridization assay showed that when the expression of let-7f was elevated, the expression of NDRG3 mRNA was accordingly reduced in rat cerebral ischemia. Taken together, our results identify a new regulatory mechanism of let-7f on NDRG3 expression in the hypoxic response of cerebral ischemia and raise the possibility that the let-7f/NDRG3 pathway may serve as a potential target for the treatment of ischemic stroke.

Entities:  

Keywords:  Cerebral ischemia; Hypoxic response; Let-7f; N-myc downstream-regulated gene-3 (NDRG3); microRNAs (miRNAs)

Mesh:

Substances:

Year:  2016        PMID: 27812761     DOI: 10.1007/s11064-016-2091-x

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  31 in total

Review 1.  [The neuroprotective effect of PACAP, VIP, and derivatives in brain ischemia].

Authors:  Marta Jóźwiak-Bebenista; Katarzyna Bednarek; Jerzy Z Nowak
Journal:  Postepy Hig Med Dosw (Online)       Date:  2008-09-18       Impact factor: 0.270

2.  MicroRNA-9 promotes differentiation of mouse bone mesenchymal stem cells into neurons by Notch signaling.

Authors:  Lijun Jing; Yonglin Jia; Jingjing Lu; Rui Han; Jinyi Li; Shuyang Wang; Tao Peng; Yanjie Jia
Journal:  Neuroreport       Date:  2011-03-30       Impact factor: 1.837

3.  A lactate-induced response to hypoxia.

Authors:  Dong Chul Lee; Hyun Ahm Sohn; Zee-Yong Park; Sangho Oh; Yun Kyung Kang; Kyoung-Min Lee; Minho Kang; Ye Jin Jang; Suk-Jin Yang; Young Ki Hong; Hanmi Noh; Jung-Ae Kim; Dong Joon Kim; Kwang-Hee Bae; Dong Min Kim; Sang J Chung; Hyang Sook Yoo; Dae-Yeul Yu; Kyung Chan Park; Young Il Yeom
Journal:  Cell       Date:  2015-04-16       Impact factor: 41.582

Review 4.  The emerging role of microRNA in stroke.

Authors:  Georgios Koutsis; Gerasimos Siasos; Konstantinos Spengos
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

Review 5.  Lesion evolution in cerebral ischemia.

Authors:  Tobias Back; Thomas Hemmen; Olaf G Schüler
Journal:  J Neurol       Date:  2004-04       Impact factor: 4.849

6.  Cloning of a novel Apaf-1-interacting protein: a potent suppressor of apoptosis and ischemic neuronal cell death.

Authors:  Guodong Cao; Michael Xiao; Fengyan Sun; Xiao Xiao; Wei Pei; Juan Li; Steven H Graham; Roger P Simon; Jun Chen
Journal:  J Neurosci       Date:  2004-07-07       Impact factor: 6.167

Review 7.  microRNAs in Cerebrovascular Disease.

Authors:  Ondřej Volný; Linda Kašičková; Dominika Coufalová; Petra Cimflová; Jan Novák
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

8.  δ-opioid receptor activation and microRNA expression of the rat cortex in hypoxia.

Authors:  Yilin Yang; Feng Zhi; Xiaozhou He; Meredith L Moore; Xuezhi Kang; Dongman Chao; Rong Wang; Dong H Kim; Ying Xia
Journal:  PLoS One       Date:  2012-12-13       Impact factor: 3.240

9.  Identification and Functional Analysis of MicroRNAs in Mice following Focal Cerebral Ischemia Injury.

Authors:  Cuiying Liu; Lei Zhao; Song Han; Junfa Li; Dongguo Li
Journal:  Int J Mol Sci       Date:  2015-10-14       Impact factor: 5.923

10.  Oxygen glucose deprivation in rat hippocampal slice cultures results in alterations in carnitine homeostasis and mitochondrial dysfunction.

Authors:  Thomas F Rau; Qing Lu; Shruti Sharma; Xutong Sun; Gregory Leary; Matthew L Beckman; Yali Hou; Mark S Wainwright; Michael Kavanaugh; David J Poulsen; Stephen M Black
Journal:  PLoS One       Date:  2012-09-11       Impact factor: 3.240

View more
  5 in total

Review 1.  The regulatory role of microRNAs in angiogenesis-related diseases.

Authors:  Li-Li Sun; Wen-Dong Li; Feng-Rui Lei; Xiao-Qiang Li
Journal:  J Cell Mol Med       Date:  2018-06-29       Impact factor: 5.310

2.  High NDRG3 expression facilitates HCC metastasis by promoting nuclear translocation of β-catenin.

Authors:  JiKui Shi; HongZhen Zheng; LingYan Yuan
Journal:  BMB Rep       Date:  2019-07       Impact factor: 4.778

Review 3.  Nervous NDRGs: the N-myc downstream-regulated gene family in the central and peripheral nervous system.

Authors:  Simone L Schonkeren; Maartje Massen; Raisa van der Horst; Alexander Koch; Nathalie Vaes; Veerle Melotte
Journal:  Neurogenetics       Date:  2019-09-04       Impact factor: 2.660

4.  High expression of NDRG3 in osteoarthritis patients.

Authors:  Long Chen; Yuanzheng Wang; Senlei Li; Wei Zhou; Li Sun
Journal:  Arthroplasty       Date:  2021-03-01

5.  LncRNA Meg3 promotes oxygen and glucose deprivation injury by decreasing angiogenesis in hBMECs by targeting the miR‑122‑5p/NDRG3 axis.

Authors:  Zhaoliang Luo; Tingliang Gong; Weihong Li; Wenqiang Tao
Journal:  Exp Ther Med       Date:  2022-08-11       Impact factor: 2.751

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.